Parasite mitochondrion

Parasite mitochondrion refers to the mitochondria present within unicellular parasites, including Apicomplexa (e.g., Plasmodium, Toxoplasma), Trypanosomatids (e.g., Trypanosoma), and helminths. These mitochondria are characterized by substantial structural and metabolic diversity compared to their mammalian counterparts, frequently adapting their morphology and enzymatic components during the life cycle. In many cases, parasite mitochondria are critical for survival, acting as sites for essential metabolic functions like electron transport, iron-sulfur cluster assembly, and cofactor biosynthesis, even when not serving as a major source of ATP[1][2][5]. Drugs such as atovaquone and ascofuranone exploit differences in the mitochondrial electron transport chain, often targeting components unique to parasites for selective inhibition[2][4][6][8]. The concept of "parasite mitochondria" is broad and non-specific, encompassing multiple species, types, and molecular targets; each may possess its own druggable components and clinical implications. Mitochondrial pathways offer validated and potential targets for antiparasitic chemotherapy, but meaningful selectivity and avoidance of host toxicity are persistent drug development challenges[4][6]. **Note:** - The term "parasite mitochondria" does not describe a single, well-defined molecular target, but rather a cellular organelle present in diverse parasite species with life-stage- and species-specific features and vulnerabilities. This entry is thus too broad and not a singular, actionable molecular target—categorizing is_incorrect as true, and use of more precise target names (such as "Plasmodium falciparum cytochrome bc1 complex") is recommended for structured data needs.

Other names

Parasite mitochondriaMitochondria of parasitic protistsApicomplexan mitochondrion (for relevant species)Plasmodium mitochondrionTrypanosome mitochondrion

Inhibition of mitochondrial electron transport chain (e.g., cytochrome bc1 complex inhibition by atovaquone), Inhibition of parasite-specific enzymes (e.g., trypanosome alternative oxidase, NADH-fumarate reductase), Disruption of mitochondrial membrane potential, Promotion of reactive oxygen species (ROS) generation